Insulin Aspart Injection, Solution
Product Images NDC 50090-4955

Product Visual Gallery

This gallery contains 45 technical images submitted to the FDA as part of the official labeling for Insulin Aspart (NDC 50090-4955). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Formula (Image 01)

Illustration showing the amino acid sequence and disulfide bond connections of insulin aspart. It depicts the A-chain with 21 amino acids and the B-chain with 30 amino acids, highlighting the specific residues and their bonding pattern that define the insulin aspart molecule.*

FDA Label Image

Figure 1 (Image 02)

A line graph depicting serum glucose levels (mg/dL) over time (hours). Two lines are shown: one solid and one dashed, illustrating different glucose level trends during a 6-hour period after treatment.*

FDA Label Image

Figure 3 (Image 03)

A line graph depicting mean blood glucose (mg/dL) over time (minutes), with time points ranging from before to after a reference point (R). The graph shows a decrease in blood glucose levels followed by a gradual increase, with error bars at each time point. The x-axis is labeled with time intervals including negative and positive values relative to R, and the y-axis shows blood glucose levels from 0 to 180 mg/dL.*

FDA Label Image

Figure 4 (Image 04)

A line graph showing free serum insulin levels (mIU/L) over time (hours). It includes two curves that depict insulin concentration changes up to 6 hours. The x-axis represents time in hours, and the y-axis represents free serum insulin concentration.*

FDA Label Image

Overview (FlexPen)

An illustration of an Insulin Aspart FlexPen injection device showing its labeled components including the pen cap, rubber stopper, cartridge, cartridge scale, dose pointer, dose selector, and push-button. The diagram visually identifies each part of the pen used for subcutaneous or intravenous insulin aspart injection.*

FDA Label Image

Novifine And Novofine Plus (Overview)

An instructional diagram showing components of NovoFine and NovoFine Plus needle caps. Both sets include a big outer needle cap, inner needle cap, needle, and protective tab, illustrating assembly parts for insulin injection needles.*

FDA Label Image

Vial Figure (Image 07)

Illustration of a vial with labels pointing to the tamper resistant cap and the rubber stopper located under the cap. The vial is unbranded and shown as a line drawing with gray shading on the bottle portion.*

FDA Label Image

Hand And Vial Figure (Image 08)

An instructional illustration depicting a hand holding a small vial, likely representing a medication vial for injection. The vial is held between the thumb and forefinger, demonstrating proper handling technique for preparing an injection.*

FDA Label Image

Figure A And Figure B (Image 09)

An instructional illustration depicting two hand positions for vial access or preparation of an injection. The images show a vial held by one hand with a stopper or cap being manipulated by the other hand, indicating steps for opening or preparing the vial for use.*

FDA Label Image

Figure C (Image 10)

An instructional illustration showing a hand holding a syringe and another hand holding a vial, with an arrow indicating the action of drawing solution from the vial into the syringe. An inset highlights the syringe with liquid inside. This diagram likely demonstrates the preparation or withdrawal of insulin aspart injection solution.*

FDA Label Image

Figure D (Image 11)

An instructional illustration labeled Figure D showing a person holding a syringe and vial, depicting the step of drawing solution from the vial into the syringe for injection preparation.*

FDA Label Image

Figure E (Image 12)

Instructional illustration showing a hand attaching a needle to a syringe. The image depicts the correct technique for assembling the injection device, highlighting the placement and grip for connecting the parts securely.*

FDA Label Image

Figure F (Image 13)

An instructional illustration labeled 'Figure F' showing a hand holding a vial upside down while drawing liquid into a syringe. An arrow indicates the direction of liquid flow from the vial to the syringe. The image demonstrates proper technique for withdrawing insulin aspart injection solution.*

FDA Label Image

Figure G (Image 14)

An instructional illustration showing a person drawing medication from a vial into a syringe. One hand holds the vial upside down while the other hand pulls the plunger to fill the syringe. The figure is labeled as Figure G.*

FDA Label Image

Figure H (Image 15)

An instructional black-and-white illustration shows a pair of hands preparing an insulin injection. One hand holds a vial upside down, while the other hand draws insulin with a syringe. An inset zoom highlights the syringe filled to a measurement line. The figure appears to be a step in medication preparation for insulin aspart injection.*

FDA Label Image

Figure I (Image 16)

An instructional illustration showing a hand holding a vial and another hand holding a syringe with its needle directed toward the vial's top, indicating the step of drawing medication from the vial using the syringe, labeled as Figure I.*

FDA Label Image

Fig. J (Image 17)

An anatomical diagram showing front and back views of a human figure. Highlighted areas on the abdomen, upper thigh, and buttocks likely indicate recommended or common injection sites for medication administration.*

FDA Label Image

Figure K (Image 18)

An instructional diagram labeled Figure K showing a person's hands handling a syringe. One hand holds the syringe barrel, while the other hand adjusts the plunger, indicating preparation or use of an injection.*

FDA Label Image

Figure L (Image 19)

An instructional illustration showing a hand holding a syringe injecting a solution subcutaneously into the skin of a forearm or upper arm, indicated by an upward-pointing arrow. The diagram visually represents the injection technique.*

FDA Label Image

Novotwist Needle (Image 20)

An illustration labeled NovoTwist showing four components: big outer needle cap, inner needle cap, needle, and protective tab, presumably for use with a syringe or pen injection device.*

FDA Label Image

Pull Off The Pen Cap (Image 21)

An instructional illustration showing a hand holding a syringe and depressing the plunger. The image indicates the action of pushing the plunger with an arrow pointing outward, likely demonstrating injection technique or dosage administration for insulin aspart injection.*

FDA Label Image

Turn The Dose Selector To Select 2 Units. (Image 22)

An instructional illustration showing a hand adjusting the dose selector on an insulin pen. The dose display indicates 2 units selected, with an arrow emphasizing the adjustment mechanism. This diagram visually explains how to set the insulin aspart injection dose using the pen device.*

FDA Label Image

Tap The Cartridge Gently (Image 23)

An instructional illustration depicting a hand holding a syringe with a needle in front of a forearm, suggesting preparation for an injection. The image includes motion lines near the syringe, indicating movement or shaking. This likely relates to the administration technique for Insulin Aspart injection solution.*

FDA Label Image

Keep The Needle Pointing Upwards (Image 24)

An instructional diagram showing a hand holding an insulin aspart pen injector. The image illustrates pushing the pen's plunger upward to deliver a dose of insulin injection solution. A small inset highlights the needle cap being removed from the device.*

FDA Label Image

Turn The Dose Selector To The Number Of Units You Need To Inject (Image 25)

An instructional illustration showing the adjustment of a dosage selector on an insulin pen injector. It depicts a close-up of a hand turning the dose knob with arrows indicating the direction, and two smaller detail images show the dose window displaying 5 units selected and 24 units selected, demonstrating how to set the dosage amount.*

FDA Label Image

Giving The Injection (Image 26)

Instructional illustration showing a hand pressing down on a vial cap or plunger of a medical injection device, with an arrow indicating downward motion. The vial is partially visible with liquid inside and measurement markings, suggesting preparation steps for injecting insulin aspart solution.*

FDA Label Image

Making Sure That The Full Dose Has Been Given (Image 27)

An illustration showing the tip of a syringe needle about to penetrate the skin, presumably demonstrating injection technique for a medication administered via injection.*

FDA Label Image

Put The Pen Cap On (Image 28)

An instructional illustration depicting a close-up of a hand holding an insulin pen device, specifically showing the action of pulling back the needle cap. The image includes a directional arrow indicating the direction to pull the cap off, demonstrating part of the preparation process for injection.*

FDA Label Image

Figure A Penfill Cartridge And Needle Components. (Image 41)

Illustration showing components of NovoFine, NovoFine Plus, and NovoTwist needles including outer/inner needle caps, needle, and paper tab. Also depicts a PenFill 3 mL cartridge with parts labeled: pen cap, cartridge holder, dose pointer, dose counter, dose selector/button, threaded end, colored band, and rubber plunger, indicating compatibility with insulin delivery devices.*

FDA Label Image

Diagram B: Attaching The Needle. (Image 43)

An instructional illustration showing insertion and turning of an insulin pen device. The image includes instructions for 'NovoFine' and 'NovoFine Plus' needles, with a hand holding the pen and rotating a component marked with a blue arrow and the letter 'B.'*

FDA Label Image

Diagram C: Pull Off The Outer Needle Cap. (Image 44)

An instructional illustration showing the steps for attaching or using the needle with a NovoFine or NovoFine Plus, and NovoTwist device. The sequence demonstrates how to connect the needle to the pen injector, highlighting hand positioning and the direction of attachment.*

FDA Label Image

Diagram D: Pull Off Inner Needle Cap. (Image 45)

Instructional illustration showing how to use NovoFine and NovoFine Plus needles with NovoTwist. The diagram depicts a hand attaching a needle, emphasizing the direction of twisting for proper needle connection.*

FDA Label Image

Figure B: Check The Penfill Cartridge. (Image 53)

An instructional illustration showing a hand holding an insulin injection pen cartridge. The focus is on the threaded end of the cartridge, which is labeled and indicated with an arrow, highlighting where the cartridge connects to the pen device.*

FDA Label Image

Figure C: Insert The Cartridge. (Image 58)

An instructional illustration showing how to attach a needle to a syringe or pen device. It depicts a hand holding a needle and another hand holding the syringe or pen, with an arrow indicating the direction to connect the needle to the device.*

FDA Label Image

Figure D: Pust The Needle Straight On. (Image 59)

An instructional illustration showing proper use of two different insulin delivery devices labeled NovoFine/NovoFine Plus and NovoTwist. The images depict hands attaching or handling needles on pen injectors, emphasizing correct needle placement/attachment.*

FDA Label Image

Figure E: Pull Off The Outer Needle Cap. (Image 60)

An instructional diagram showing how to use NovoFine and NovoTwist needle types. It features arrows indicating the action needed to operate or attach each needle type, one on the left labeled 'NovoFine NovoFine Plus' and one on the right labeled 'NovoTwist.' The image visually guides users on handling different needle options.*

FDA Label Image

Figure F: Pull Off The Inner Needle Cap. (Image 61)

An instructional diagram showing two labeled connectors for insulin delivery devices: 'NovoFine' and 'NovoFine Plus' on the left, and 'NovoTwist' on the right. Each label is accompanied by an arrow pointing to the respective connector component, illustrating compatibility or assembly steps.*

FDA Label Image

Figure I: Injection Sites (Image 62)

Illustration showing recommended injection sites for Insulin Aspart injection, including the upper arms, abdomen, upper thighs, and buttocks. The diagram highlights these areas on a human figure to guide proper injection placement.*

FDA Label Image

Figure J: Count Slowly. (Image 63)

An instructional illustration showing a hand holding an insulin pen injector with an extended needle, positioned for injection into the forearm. A speech bubble instructs to count slowly from 1 to 6, indicating timing or steps for administration.*

FDA Label Image

Figure K: Lead The Needle Tip Into The Outer Cap. (Image 65)

An instructional illustration showing how to connect a cap to or remove it from the tip of a syringe or injection device, indicated by two large blue arrows pointing in opposite directions.*

FDA Label Image

Figure L: Unscrew The Needle. (Image 66)

Instructional illustration showing how to remove the cartridge holder from a pen device by twisting it counterclockwise, with a close-up on the cartridge holder and a hand gripping the pen. The diagram is for an injection device used with insulin aspart.*

FDA Label Image

Figure M: Put The Cap On The Device. (Image 67)

Illustration showing a hand holding an insulin cartridge or pen, with an arrow indicating the action of inserting or preparing the cartridge or pen for use. The image appears instructional, related to the administration of insulin aspart injection.*

FDA Label Image

Figure G: Insulin Squirts. (Image 68)

The image shows a vial of Insulin Aspart injection, solution, featuring a clear cylindrical container with a blue and white label and a cap with an attached thin curved needle or catheter. The product is labeled with a concentration of 100 units per mL and is produced by A-S Medication Solutions for intravenous and subcutaneous use.*

FDA Label Image

Figure H: Select Your Dose. (Image 69)

Illustration showing a close-up of a dose selector on a medical device, demonstrating how to set the dose with a dose pointer aligned to the number 12, indicating an example of 12 units selected. The image labels the dose counter, dose selector, and dose pointer to guide dose adjustment.*

FDA Label Image

Label Image (Lbl500904955)

Insulin Aspart 100 Units/mL injection solution label by A-S Medication Solutions. It is a 10 mL multi-dose vial for intravenous and subcutaneous use. The label includes lot number, warnings to keep in a cool place, and a dosage peak image insert barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.